Canada authorises compulsory licences for COVID-19 shortfalls
27-03-2020
Jonathan Weiss / Shutterstock.com
Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million ($517 million) won by Dow Chemical at the country’s federal court of appeal.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Nova, Dow, Canada, Supreme Court, big pharma
